Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Cell. 2010 Jul 13;18(1):7-8. doi: 10.1016/j.ccr.2010.06.006.

The molecular biology of myeloproliferative disorders.

Author information

1
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. jradich@fhcrc.org

Abstract

The myeloproliferative disorders (MPDs) are a spectrum of clonal disorders of the hematopoietic system. The discovery of activating mutations of the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and primary myelofibrosis has lead to in vitro and animal model studies that promise to lead to therapeutic advances.

PMID:
20609348
DOI:
10.1016/j.ccr.2010.06.006
Free full text

Publication type

Publication type

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center